View in EDS HTML Full Text PDF Full Text

2227. Outcomes in Patients with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane–Tazobactam (C/T) Treatment of Nosocomial Pneumonia (ASPECT-NP).

Saved in:

Bibliographic Details
Title:	2227. Outcomes in Patients with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane–Tazobactam (C/T) Treatment of Nosocomial Pneumonia (ASPECT-NP).
Authors:	Huntington, Jennifer A¹ (AUTHOR), Yu, Brian¹ (AUTHOR), Li, Linping¹ (AUTHOR), Jensen, Erin¹ (AUTHOR), Bruno, Christopher¹ (AUTHOR), Rhee, Elizabeth G¹ (AUTHOR)
Source:	Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS760-S761. 2p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	23288957
DOI:	10.1093/ofid/ofz360.1905